Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - endometrial
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Human Serous
Endometrial
Cancer Cell Lines CRISPR-edited to knock-in FBXW7 mutations for Use in Cancer related Molecular and Cellular Studies
This technology includes
endometrial
cancer cell lines for use in molecular and cellular studies to determine the effects of cancer-associated FBXW7 (F-box and WD repeat domain-containing 7) mutations, including but not limited to biochemical studies, proteomic studies, and drug sensitivity/resistance studies. Clustered Regularly Interspaced Palindromic...
Published: 10/28/2024
|
Inventor(s):
Mary Urick
,
Daphne Bell
Keywords(s):
CANCER
,
Cell
,
CRISPR-edited
,
endometrial
,
FBXW7
,
Human
,
Knock-in
,
Lines
,
Mutations
,
Serous
,
VCXXXX
,
WIXXXX
,
XEXXXX
Category(s):
TherapeuticArea > Oncology
,
Application > Therapeutics
,
Application > Research Materials
Prostatic Adenocarcinoma Cells Expressing or Lacking the Tumor Suppressor Gene PTEN
PTEN is a tumor suppressor gene that is frequently deleted or mutated in a variety of human cancers, including prostate, breast,
endometrial
, lung, and ovarian cancers. In prostate cancer cells, PTEN deletion is the most common event observed. The loss of PTEN is thought to play and important role in tumor cell proliferation and metastasis due to...
Published: 4/8/2024
|
Inventor(s):
Michael Quon
,
Derek Leroith
Keywords(s):
ADENOCARCINOMA
,
BREAST CANCER
,
CA1XXX
,
CANCER
,
CAXXXX
,
CCXXXX
,
Cells
,
CHARACTERIZATION
,
Chromosome 7, monosomy
,
CXXXXX
,
Deletion 7
,
endometrial
,
Expressing
,
Gene
,
IGF1R
,
lung cancer
,
MEN 1
,
OVARIAN CANCER
,
PROSTATE CANCER
,
PTEN
,
tumor suppressor
,
Zollinger-Ellison syndrome
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Oncology
,
Application > Diagnostics
,
Application > Research Materials